Kura Oncology, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Kura Oncology, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Kura Oncology, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $500K, a 16.7% decline year-over-year.
  • Kura Oncology, Inc. annual Operating Lease, Payments for 2023 was $2.1M, a 8.7% decline from 2022.
  • Kura Oncology, Inc. annual Operating Lease, Payments for 2022 was $2.3M, a 9.52% increase from 2021.
  • Kura Oncology, Inc. annual Operating Lease, Payments for 2021 was $2.1M, a 600% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.1M -$200K -8.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $2.3M +$200K +9.52% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $2.1M +$1.8M +600% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $300K -$200K -40% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $500K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.